Skip to content

Clinical trials

Hypersensitivity trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Country / region: Belgium Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20082
20102
20141
20161
20171
20182
20193
20214
20222
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting2
Recruiting2
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Brugmann University Hospital3
Celgene2
Cogent Biosciences, Inc.2
University Hospital, Antwerp2
ALK-Abelló A/S1
Artu Biologicals1
AstraZeneca1
BioTech Tools S.A.1
GlaxoSmithKline1
Helmholtz Zentrum München1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity24
Immune System Diseases6
Hypersensitivity, Immediate3
Asthma2
Bronchial Diseases2
Eosinophilia2
Eosinophilic Esophagitis2
Esophageal Diseases2
Esophagitis2
Gastroenteritis2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.